Aurora Diagnostics acquires CytoPath

Aurora Diagnostics, a leading independent pathology services and cancer diagnostics company, has acquired CytoPath, bringing to 30 the number of affiliated local pathology practices around the country.

Based just south of Birmingham in Alabaster, Ala., CytoPath is a physician-owned medical practice providing surgical pathology and cytopathology services to eight hospitals and five referring physician group clients in Central and Southern Alabama.

"We are very pleased to welcome the highly regarded CytoPath team to our growing family of pathology practices," said Daniel D. Crowley, CEO of Aurora Diagnostics. "Their history of supporting local community hospitals and physicians in Alabama makes the CytoPath team an ideal addition to our organization."